Global Webinar 1: Current Knowledge and Future Directions: Psoriasis and Heart Disease

Agenda

Welcome and Introduction

Andy Blauvelt

Pathophysiologic Links Between Psoriasis and Heart Disease

Michael Garshick

Exploring Whether Systemic Therapy for Psoriasis Improves Heart Disease in Clinical Trials

Joel Gelfand

Investigating Real-World Databases to Determine Whether Systemic Therapy for Psoriasis Improves Heart Disease

Mona Ståhle

Q & A and Closing Comments

Andy Blauvelt

Program Chair

Andrew Blauvelt, MD, MBA

Oregon Medical Research Center

Portland, Oregon, United States

IPC Board Member

Bio

Program Faculty

Joel Gelfand, MD, MSCE

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Treasurer

Bio

Michael Garshick, MD

NYU Langone Health

New York, New York, United States

Bio

Mona Ståhle, MD, PhD

Department of Medicine, Karolinska Institutet

Stockholm, Sweden

Bio